Literature DB >> 19070289

Differential deposition of manganese in the rat brain following subchronic exposure to manganese: a T1-weighted magnetic resonance imaging study.

Yoram Finkelstein1, Na Zhang, Vanessa A Fitsanakis, Malcolm J Avison, John C Gore, Michael Aschner.   

Abstract

BACKGROUND: Manganism is a central nervous system disorder caused by toxic exposure to manganese. Manganism has been related to occupational exposures, liver diseases, prolonged parenteral nutrition, and abuse of illicit drugs. Initially manifested by a reversible neuropsychiatric syndrome (locura manganica), the main symptoms and signs of manganism are emotional lability, compulsive behavior and visual hallucinations. Locura manganica is followed by an irreversible extrapyramidal syndrome, the onset of which occurs years after chronic exposure.
OBJECTIVES: To characterize the regional distribution of Mn in the rat brain after subchronic exposure to Mn. This animal model holds special clinical relevance, reflecting the earlier clinical stages of manganism before chronic exposure to Mn exerts its irreversible effects.
METHODS: Sprague-Dawley rats were intravenously injected with MnCl2 weekly, for a total of 14 weeks - approximately 1/10 of the lifetime of the rat. T1-weighted magnetic resonance imaging was used to detect the distribution of Mn deposition in brain tissues, as evidenced by areas of T1-weighted hyperintense signals.
RESULTS: A consistent region-specific pattern of T1-weighted hyperintensities was observed in the brains of Mn-treated rats. Cortical hyperintensities were prominent in the hippocampus and dentate gyrus. Hyperintensities were also observed in the olfactory bulbs, pituitary gland, optic nerves and chiasma, pons, midbrain tegmentum, habenula, lentiform and caudate nuclei, thalamus, chorioid plexus and cerebellar hemispheres.
CONCLUSIONS: Prominent Mn depositions, evidenced by T1-weighted hyperintensities in the hippocampus after subacute exposure to Mn, are compatible with the clinical picture of manganism during its early stages, and may explain its pathophysiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19070289      PMCID: PMC8988916     

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  23 in total

1.  Occupational exposure to manganese, copper, lead, iron, mercury and zinc and the risk of Parkinson's disease.

Authors:  J M Gorell; C C Johnson; B A Rybicki; E L Peterson; G X Kortsha; G G Brown; R J Richardson
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

2.  Loss of cortical acetylcholine enhances amphetamine-induced locomotor activity.

Authors:  A Mattsson; K Pernold; S O Ogren; L Olson
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

3.  Magnetic resonance imaging studies of the brains of anesthetized rats treated with manganese chloride.

Authors:  R E London; G Toney; S A Gabel; A Funk
Journal:  Brain Res Bull       Date:  1989-09       Impact factor: 4.077

Review 4.  Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations.

Authors:  Afonso C Silva; Jung Hee Lee; Ichio Aoki; Alan P Koretsky
Journal:  NMR Biomed       Date:  2004-12       Impact factor: 4.044

5.  Manganese-enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: dose-dependent and temporal evolution of T1 contrast.

Authors:  Jung Hee Lee; Afonso C Silva; Hellmut Merkle; Alan P Koretsky
Journal:  Magn Reson Med       Date:  2005-03       Impact factor: 4.668

6.  Occupational Mn parkinsonism: magnetic resonance imaging and clinical patterns following CaNa2-EDTA chelation.

Authors:  G Discalzi; E Pira; E Herrero Hernandez; C Valentini; M Turbiglio; F Meliga
Journal:  Neurotoxicology       Date:  2000-10       Impact factor: 4.294

7.  Role of manganese in dystonia.

Authors:  A Barbeau; N Inoué; T Cloutier
Journal:  Adv Neurol       Date:  1976

Review 8.  High signal intensities on T1-weighted MRI as a biomarker of exposure to manganese.

Authors:  Yangho Kim
Journal:  Ind Health       Date:  2004-04       Impact factor: 2.179

9.  Studies of tissue NMR relaxation enhancement by manganese. Dose and time dependences.

Authors:  Y S Kang; J C Gore
Journal:  Invest Radiol       Date:  1984 Sep-Oct       Impact factor: 6.016

10.  A Parkinsonian syndrome in methcathinone users and the role of manganese.

Authors:  Ainārs Stepens; Ināra Logina; Viesturs Liguts; Pauls Aldins; Ilze Eksteina; Ardis Platkājis; Inese Mārtinsone; Elmārs Tērauds; Baiba Rozentāle; Michael Donaghy
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245

View more
  12 in total

1.  Brain deposition and neurotoxicity of manganese in adult mice exposed via the drinking water.

Authors:  Saritha Krishna; Celia A Dodd; Shahryar K Hekmatyar; Nikolay M Filipov
Journal:  Arch Toxicol       Date:  2013-07-06       Impact factor: 5.153

2.  Manganese uptake and distribution in the brain after methyl bromide-induced lesions in the olfactory epithelia.

Authors:  Khristy J Thompson; Ramon M Molina; Thomas Donaghey; Sandeep Savaliya; James E Schwob; Joseph D Brain
Journal:  Toxicol Sci       Date:  2010-12-20       Impact factor: 4.849

3.  Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma.

Authors:  Oliver Bähr; Elke Hattingen; Johannes Rieger; Joachim P Steinbach
Journal:  Neuro Oncol       Date:  2011-07-31       Impact factor: 12.300

Review 4.  Identification of mineral deposits in the brain on radiological images: a systematic review.

Authors:  Maria del C Valdés Hernández; Lucy C Maconick; Elizabeth M J Tan; Joanna M Wardlaw
Journal:  Eur Radiol       Date:  2012-06-12       Impact factor: 5.315

5.  Transcranial Magnetic Stimulation and Deep Brain Stimulation in the treatment of alcohol dependence.

Authors:  L Alba-Ferrara; F Fernandez; R Salas; G A de Erausquin
Journal:  Addict Disord Their Treat       Date:  2014-12

Review 6.  Manganese Toxicity Associated With Total Parenteral Nutrition: A Review.

Authors:  Justin P Reinert; Laramie D Forbes
Journal:  J Pharm Technol       Date:  2021-07-31

Review 7.  Manganese (Mn) and iron (Fe): interdependency of transport and regulation.

Authors:  Vanessa A Fitsanakis; Na Zhang; Stephanie Garcia; Michael Aschner
Journal:  Neurotox Res       Date:  2009-11-18       Impact factor: 3.911

8.  Evaluation of neurobehavioral and neuroinflammatory end-points in the post-exposure period in rats sub-acutely exposed to manganese.

Authors:  Dinamene Santos; Santos Dinamene; M Camila Batoréu; Batoreu M Camila; I Tavares de Almeida; L Davis Randall; M Luísa Mateus; Mateus M Luisa; Vanda Andrade; Andrade Vanda; Ruben Ramos; Ramos Ruben; Edite Torres; Torres Edite; Michael Aschner; Aschner Michael; A P Marreilha dos Santos; A P Marreilha Dos Santos
Journal:  Toxicology       Date:  2013-09-20       Impact factor: 4.221

Review 9.  Brain manganese and the balance between essential roles and neurotoxicity.

Authors:  Rekha C Balachandran; Somshuvra Mukhopadhyay; Danielle McBride; Jennifer Veevers; Fiona E Harrison; Michael Aschner; Erin N Haynes; Aaron B Bowman
Journal:  J Biol Chem       Date:  2020-03-18       Impact factor: 5.157

10.  Manganese in human parenteral nutrition: considerations for toxicity and biomonitoring.

Authors:  Dinamene Santos; Camila Batoreu; Luisa Mateus; A P Marreilha Dos Santos; Michael Aschner
Journal:  Neurotoxicology       Date:  2013-11-01       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.